Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT01600352 |
Date of registration:
|
15/05/2012 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Specific Autoantibody Testing in Patients With Interstitial Lung Disease
|
Scientific title:
|
To Evaluate the Clinical Utility of Specific Autoantibody Testing in Patients With Interstitial Lung Disease |
Date of first enrolment:
|
May 2012 |
Target sample size:
|
20 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01600352 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Singapore
| | | | | | | |
Contacts
|
Name:
|
Su Ying Low, BMBCh |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Singapore General Hospital |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Patients 21 years old and older
2. Patients with interstitial lung disease who have been found to have weak positive ANA
(1:400 titre) with no overt connective tissue disease manifestations OR
borderline/negative ANA with some clinical suggestion of connective tissue disease
will be offered specific autoantibody testing
Exclusion Criteria:
1. Inability and unwillingness to sign informed consent
2. Patients who are pregnant or have underlying malignancy
Age minimum:
21 Years
Age maximum:
90 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Interstitial Lung Disease
|
Primary Outcome(s)
|
Clinical utility of specific autoantibody testing
[Time Frame: 3 months]
|
Secondary ID(s)
|
2012/245/Cautoantibodies
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|